#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	5182	16S	1529	1529	100.0	16S.l6.c30.ctg.1	2703	565.6	1	SNP	n	C1184T	0	.	.	1184	1184	C	1793	1793	C	711	C,A	627,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	8354	23S	2890	2890	99.86	23S.l15.c4.ctg.1	4093	610.2	0	.	n	.	0	T695C	SNP	695	695	T	1390	1390	C	641	C,A,T	581,1,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	8354	23S	2890	2890	99.86	23S.l15.c4.ctg.1	4093	610.2	0	.	n	.	0	G1337A	SNP	1337	1337	G	2032	2032	A	743	A	699	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	8354	23S	2890	2890	99.86	23S.l15.c4.ctg.1	4093	610.2	0	.	n	.	0	T1971C	SNP	1971	1971	T	2666	2666	C	723	C,A,G	647,2,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	8354	23S	2890	2890	99.86	23S.l15.c4.ctg.1	4093	610.2	1	SNP	n	C2597T	1	C2597T	SNP	2597	2597	C	3292	3292	T	687	T,C,A,G	610,1,1,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	8354	23S	2890	2890	99.86	23S.l15.c4.ctg.1	4093	610.2	1	SNP	n	A2045G	0	.	.	2045	2045	A	2740	2740	A	707	A	648	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
folP.WHO_P_01364c	folP.WHO_P_01364c	1	1	27	790	folP	852	852	100.0	folP.l6.c4.ctg.1	2051	115.0	1	SNP	p	R228S	1	.	.	682	684	AGC	1263	1265	AGC	173;172;171	A;G,C;C	157;160,1;153	folP.WHO_P_01364c:1:1:R228S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	1590	gyrA	2751	2751	99.85	gyrA.l6.c17.ctg.1	3927	121.0	1	SNP	p	S91F	0	.	.	271	273	TCC	891	893	TCC	133;134;133	T;C;C,T	119;125;124,1	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	1590	gyrA	2751	2751	99.85	gyrA.l6.c17.ctg.1	3927	121.0	1	SNP	p	D95N	0	.	.	283	285	GAC	903	905	GAC	134;133;133	G,T;A;C	127,1;118;123	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	1590	gyrA	2751	2751	99.85	gyrA.l6.c17.ctg.1	3927	121.0	1	SNP	p	D95G	0	.	.	283	285	GAC	903	905	GAC	134;133;133	G,T;A;C	127,1;118;123	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_Y_01506	mtrR.WHO_Y_01506	1	1	539	692	mtrR	633	633	99.21	mtrR.l15.c4.ctg.1	1942	107.0	0	.	p	.	0	A39T	NONSYN	115	117	GCC	694	696	ACC	189;190;190	A;C;C	170;172;172	.	.
mtrR.WHO_Y_01506	mtrR.WHO_Y_01506	1	1	539	692	mtrR	633	633	99.21	mtrR.l15.c4.ctg.1	1942	107.0	0	.	p	.	0	R44H	NONSYN	130	132	CGC	709	711	CAC	184;184;184	C,A;A;C	164,1;167;171	.	.
mtrR.WHO_Y_01506	mtrR.WHO_Y_01506	1	1	539	692	mtrR	633	633	99.21	mtrR.l15.c4.ctg.1	1942	107.0	0	.	p	.	0	Y105H	NONSYN	313	315	TAC	892	894	CAC	189;189;189	C;A,T;C	174;172,1;174	.	.
mtrR.WHO_Y_01506	mtrR.WHO_Y_01506	1	1	539	692	mtrR	633	633	99.21	mtrR.l15.c4.ctg.1	1942	107.0	1	SNP	p	G45D	0	.	.	133	135	GGC	712	714	GGC	185;186;185	G;G;C	167;172;172	mtrR.WHO_Y_01506:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	524	mtrR_promoter	250	250	100.0	mtrR_promoter.l15.c4.ctg.1	1617	97.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	1716	parC	2304	2304	100.0	parC.l6.c30.ctg.1	3550	144.8	1	SNP	p	D86N	0	.	.	256	258	GAC	986	988	GAC	198;198;202	G;A;C	170;163;181	parC.WHO_P_00203c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	1716	parC	2304	2304	100.0	parC.l6.c30.ctg.1	3550	144.8	1	SNP	p	S87W	0	.	.	259	261	AGT	989	991	AGT	201;201;202	A,T,G;G;T,G	164,1,1;181;170,1	parC.WHO_P_00203c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	1716	parC	2304	2304	100.0	parC.l6.c30.ctg.1	3550	144.8	1	SNP	p	S87R	0	.	.	259	261	AGT	989	991	AGT	201;201;202	A,T,G;G;T,G	164,1,1;181;170,1	parC.WHO_P_00203c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	1716	parC	2304	2304	100.0	parC.l6.c30.ctg.1	3550	144.8	1	SNP	p	S87I	0	.	.	259	261	AGT	989	991	AGT	201;201;202	A,T,G;G;T,G	164,1,1;181;170,1	parC.WHO_P_00203c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	1716	parC	2304	2304	100.0	parC.l6.c30.ctg.1	3550	144.8	1	SNP	p	S88P	0	.	.	262	264	TCC	992	994	TCC	203;206;207	T,G;C;C,A	178,1;178;181,1	parC.WHO_P_00203c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	1398	parE	1986	1986	100.0	parE.l6.c17.ctg.1	3206	130.7	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1875	1877	GGC	166;167;167	G;G;C	155;148;147	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.2.001	penA.2.001	1	1	27	1274	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2914	131.0	1	SNP	p	A311V	0	.	.	931	933	GCA	1521	1523	GCA	197;197;198	G;C,T;A	180;178,1;182	penA.2.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	1274	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2914	131.0	1	SNP	p	I312M	0	.	.	934	936	ATC	1524	1526	ATC	198;199;202	A;T;C	182;182;184	penA.2.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	1274	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2914	131.0	1	SNP	p	V316P	0	.	.	946	948	GTG	1536	1538	GTG	200;198;197	G;T;G	187;173;182	penA.2.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	1274	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2914	131.0	1	SNP	p	V316T	0	.	.	946	948	GTG	1536	1538	GTG	200;198;197	G;T;G	187;173;182	penA.2.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	1274	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2914	131.0	1	SNP	p	T484S	0	.	.	1450	1452	ACC	2040	2042	ACC	131;131;130	A;C;C	123;120;121	penA.2.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	1274	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2914	131.0	1	SNP	p	A502P	0	.	.	1504	1506	GCG	2094	2096	GCG	137;139;137	G;C;G	127;118;122	penA.2.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	1274	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2914	131.0	1	SNP	p	A502V	0	.	.	1504	1506	GCG	2094	2096	GCG	137;139;137	G;C;G	127;118;122	penA.2.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	1274	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2914	131.0	1	SNP	p	G543S	0	.	.	1627	1629	GGC	2217	2219	GGC	141;141;141	G,C;G;C	119,1;130;124	penA.2.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	1274	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2914	131.0	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2226	2228	GGC	141;139;140	G;G,T;C,T	119;120,1;118,2	penA.2.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	1274	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2914	131.0	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2244	2246	CCG	139;140;140	C,A;C,G;G	115,1;124,1;117	penA.2.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	1782	ponA	2397	2397	99.96	ponA.l15.c4.ctg.1	3684	145.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	1008	porA	1146	1146	99.83	porA.l15.c4.ctg.1	2408	125.4	0	.	p	.	0	M83fs	FSHIFT	247	247	A	859	859	C	155	C	141	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	928	porB1b	1035	1035	96.01	porB1b.l6.c4.ctg.1	1944	140.1	0	.	p	.	0	E48K	NONSYN	142	144	GAA	664	666	AAA	182;183;183	A;A;A	160;161;160	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	928	porB1b	1035	1035	96.01	porB1b.l6.c4.ctg.1	1944	140.1	0	.	p	.	0	T87A	NONSYN	259	261	ACT	781	783	GCT	166;166;166	G,A;C;T	157,1;152;153	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	928	porB1b	1035	1035	96.01	porB1b.l6.c4.ctg.1	1944	140.1	0	.	p	.	0	G189S	NONSYN	565	567	GGC	1087	1089	AGC	182;182;184	A,C;G;C	165,1;168;170	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	928	porB1b	1035	1035	96.01	porB1b.l6.c4.ctg.1	1944	140.1	0	.	p	.	0	Y211fs	FSHIFT	631	631	T	1153	1153	T	194	T	178	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	928	porB1b	1035	1035	96.01	porB1b.l6.c4.ctg.1	1944	140.1	1	SNP	p	G120K	0	.	.	358	360	GGT	880	882	GGT	169;169;169	G;G,T;T,G	152;147,1;143,2	porB1b.WHO_U_02278c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	928	porB1b	1035	1035	96.01	porB1b.l6.c4.ctg.1	1944	140.1	1	SNP	p	A121D	0	.	.	361	363	GCC	883	885	GCC	168;167;168	G;C;C	146;139;150	porB1b.WHO_U_02278c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	928	porB1b	1035	1035	96.01	porB1b.l6.c4.ctg.1	1944	140.1	1	SNP	p	A121N	0	.	.	361	363	GCC	883	885	GCC	168;167;168	G;C;C	146;139;150	porB1b.WHO_U_02278c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	3366	rpoB	4179	4179	100.0	rpoB.l15.c4.ctg.1	5596	180.5	1	SNP	p	H553N	1	.	.	1657	1659	AAT	2332	2334	AAT	200;200;199	A;A;T	189;189;185	rpoB.WHO_M_02157:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	550	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1673	98.5	1	SNP	p	V57M	1	.	.	169	171	ATG	888	890	ATG	185;185;185	A;T;G	170;175;172	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
